8-K/A
Current Report
Spero Therapeutics, Inc. Filed Acc 0001193125-23-256865
Bylaws or fiscal year change · Shareholder vote results
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d563868d8ka.htm…